Latest S-1 registration statements

Profusa, Inc. filed an S-1 registration statement for the resale of up to 42.6 million common shares, including those tied to a $100 million committed equity facility with Ascent Partners, and revealed a new treasury strategy to invest proceeds in Bitcoin.

Grayscale Solana Trust (SOL) is amending its S-1 filing to list as an ETF on NYSE Arca and implement a SOL staking program, aiming to enhance investor access and yield.

Sonim Technologies has entered into a $500 million committed equity facility with Chardan Capital Markets and is selling its enterprise 5G solutions business for $15 million, while facing Nasdaq delisting concerns.

SolarWindow Technologies files an S-1 registration statement for the resale of up to 25.16 million common shares by existing stockholders, highlighting ongoing R&D and future financing needs.

Bitwise Investment Advisers, LLC has filed an S-1/A for its Bitwise Solana Staking ETF (BSOL), aiming to provide investors with Solana exposure and staking yield on the Cboe BZX Exchange.

Alliance Laundry Holdings Inc. has filed to register an additional 3.9 million shares of common stock for sale, increasing its public offering.

Glucotrack, Inc. filed an S-1/A to register shares for resale under a new $20.0 million committed equity financing facility, while detailing significant progress in its implantable glucose monitor development and ongoing Nasdaq listing challenges.

Bluerock Homes Trust, Inc. is offering up to 14,000,000 shares of Series B Redeemable Preferred Stock at $25.00 per share to fund future investments and general corporate purposes.

Actelis Networks, Inc. filed an S-1 registration statement for the resale of up to 15.2 million shares by White Lion Capital, LLC, tied to a new $30 million equity line of credit and a private placement, amidst ongoing Nasdaq compliance challenges.

GivBux, a Fin-Tech company, filed an S-1/A registration statement for the resale of 10.9 million shares by a selling stockholder, reporting increased revenues but widening net losses and significant going concern doubts.

Apex Treasury Corporation, a blank check company, filed an S-1/A for an initial public offering of 25 million units at $10.00 each, targeting high-growth sectors like blockchain, AI, and renewable energy for its initial business combination.

Tvardi Therapeutics, formed from a reverse merger with Cara Therapeutics, filed an S-1/A for the resale of 2.08 million common shares by existing stockholders, as it advances its STAT3 inhibitor pipeline for fibrosis-driven diseases.

Twin Hospitality Group Inc. filed an S-1 registration statement for the resale of up to 10,885,725 Class A Common Stock shares by White Lion Capital LLC, aiming to raise up to $50 million to address significant debt obligations.

Idaho Copper Corporation files S-1 for a public offering of 781,250 shares to fund its CuMo Project, despite significant net losses and going concern doubts.

Amatuhi Holdings, Inc., a Japanese operator of disability group homes, filed an amended S-1 registration statement for its initial public offering of 1,000,000 shares on the Nasdaq Capital Market.

American Rebel Holdings, Inc. filed an S-1 registration statement for the resale of up to 15,119,681 shares of common stock by selling stockholders, with no direct proceeds to the company from the stock sales.

Osprey Bitcoin Trust files an amended registration statement to convert its structure into an exchange-traded product, aiming to enhance liquidity and narrow its historical discount to net asset value.

MapLight Therapeutics, a clinical-stage biopharmaceutical company, is launching its initial public offering to fund the advancement of its central nervous system disorder pipeline, despite ongoing substantial losses and a 'going concern' warning.

Grayscale Dogecoin Trust (DOGE) files an S-1/A amendment to register its Shares for public listing on NYSE Arca as an ETF, aiming to provide cost-effective exposure to Dogecoin.

iSpecimen Inc. filed an amended S-1 registration statement, revealing continued net losses, a new Solana-based corporate treasury initiative, and a resale offering of 1.56 million shares by selling stockholders.

CISO Global, a cybersecurity firm, filed an S-1 registration statement for the resale of up to 39,062,500 common shares by B. Riley Principal Capital, LLC, stemming from a potential $15 million Series B Preferred Stock offering.

Iron Horse Acquisition II Corp. filed an amended registration statement for its $200 million initial public offering, targeting media and entertainment businesses.

Dolphin Entertainment, Inc. filed an S-1 registration statement to register up to 9,244,698 shares of common stock for resale by Lincoln Park Capital Fund, LLC, enabling a potential $15 million equity financing facility.

Guident Corp. files S-1/A for Nasdaq IPO, detailing remote monitoring and control services for autonomous vehicles and robots amid significant losses.

GigCapital8 Corp. filed an S-1MEF to increase its public offering of Class A ordinary shares by up to 2.53 million, including over-allotment, to fund its initial business combination.

Inspire Veterinary Partners, Inc. filed an S-1 registration statement for the potential resale of up to 46.4 million shares of Class A common stock by selling stockholders, including shares from Series B preferred stock conversion and warrant exercises.

USA Rare Earth, Inc. filed an S-1 registration statement for the resale of 8.33 million common shares by a selling stockholder, while announcing a key acquisition and management changes amid ongoing development of its domestic rare earth magnet supply chain.

Algorhythm Holdings has divested its karaoke business to focus on AI-enabled logistics, facing significant financial losses and a going concern warning.

Classover Holdings, Inc. (KIDZ) reported a significant increase in net losses and a decrease in revenue for the first half of 2025, despite completing a business combination and raising substantial capital for a new Solana-centric digital asset treasury strategy.

Pre-clinical biotech Revium Rx files an S-1/A for a self-underwritten initial public offering to fund its lipid-based therapies for antibiotic resistance and cancer, despite a history of significant losses.